- Bortezomib, sold
under the
brand name
Velcade among others, is an anti-cancer
medication used to
treat multiple myeloma and
mantle cell lymphoma. This...
- research. It is
particularly known for
bringing bortezomib (marketed as
Velcade)
through clinical trials to
approval for
treatment of
patients with multiple...
- drug
against multiple myeloma. When
bortezomib is used by the
trade name
Velcade, the
combination is
called Vel/Dex (or Vel-Dex or Veldex).
Bortezomib is...
- present".
Green tea
interferes with the
chemotherapy drug
bortezomib (
Velcade) and
other boronic acid-based
proteasome inhibitors, and
should be avoided...
-
Darzalex Eprex Erleada Imbruvica Procrit Rybrevant Talvey Tecvayli Valchlor Velcade Yondelis Zytiga Cardiovascular, metabolism, and
retina therapies Xarelto...
-
clinical trials across a
range of
disease areas, and is the co-developer of
Velcade, a drug used to
treat multiple myeloma.
Elliott was born in Cardiff, Wales...
- in
cancer drug research, for US$8.8 billion. The
acquisition brought in
Velcade, a drug
indicated for
hematological malignancies, as well as a portfolio...
-
tested or
approved in 2003,
including Avastin, Erbitux, Genasense, and
Velcade, with
mixed results.
Developments in HIV/AIDS
prevention included the unsuccessful...
-
brand names and lower-case
letters for
generic drug names, e.g., VRd for
Velcade (brand name for bortezomib),
Revlimid (brand name for lenalidomide) and...
-
Bosutinib (Bosulif)
Ponatinib (Iclusig)
Asciminib (Scemblix)
Bortezomib (
Velcade) is an apoptosis-inducing
proteasome inhibitor drug that
causes cancer...
